Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
JCSE01 - Perspectives for Lung Cancer Early Detection
- 07:30 - 11:15
- 9/23/2018
- Location: Room 202 BD
- Type: Joint IASLC/CSCO/CAALC Session
- Track: Screening and Early Detection
-
+
JCSE01.19 - ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line
11:15 - 11:15 | Presenter: Baohui Han | Author(s): Jun Lu, Wei Zhang, Bo Yan, Lele Zhang, Jie Qian, Bo Zhang, Shuyuan Wang
- Abstract
Loading... -
+
JCSE01.21 - Different Responses to Osimertinib in Primary and Acquired EGFR T790M-Mutant NSCLC Patients
11:15 - 11:15 | Presenter: Shuyuan Wang | Author(s): Bo Zhang, Baohui Han
- Abstract
Loading...
-
+
MA01 - Early Stage Lung Cancer: Questions and Controversies
- 10:30 - 12:00
- 9/24/2018
- Location: Room 202 BD
- Type: Mini Oral Abstract Session
- Track: Treatment of Early Stage/Localized Disease
-
+
MA01.01 - Proposal on Incorporating Lymphovascular Invasion as a T-Descriptor for Stage I Non-Small Cell Lung Cancer
10:30 - 10:35 | Presenter: Shuyuan Wang | Author(s): Bo Zhang, Jianlin Xu, Rong Qiao, Baohui Han, Bo Yan, Yu Dong
- Abstract
Loading...
-
+
MA02 - Improving Outcomes for Patients with Lung Cancer
- 10:30 - 12:00
- 9/24/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA02.06 - A Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined with Yangzheng Xiaoji in Advanced NSCLC
11:05 - 11:10 | Presenter: Ligang Xing | Author(s): Junsheng Wang, Luming Li, Zhiyong Ma, Changlu Hu, Haibo Zhang, Li Shan, Zhendong Chen, Jiandong Zhang, Qin Zhou, Shegan Gao, Xuezhen Ma, Ping Sun, Qinyou Ren, Meina Wu, Jin Wu, Jingao Li, Juntao Yao, Hongbing Ma, Wei Wang, Wenxiu Yao, Delin Wang, Jingbo Kang, Guixin Li, Xiuwen Wang, Wanqi Zhu, Jie Wang, Jinming Yu
- Abstract
Loading...
-
+
OA07 - Oligometastasis: What Should Be the State-Of-The-Art?
- 15:15 - 16:45
- 9/24/2018
- Location: Room 107
- Type: Oral Abstract Session
- Track: Oligometastatic NSCLC
-
+
OA07.06 - Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.
16:10 - 16:20 | Presenter: Fang Hu | Author(s): Jianlin Xu, Bo Zhang, Changhui Li, Wei Nie, Ping Gu, Ping Hu, Huimin Wang, Yujun Zhang, Yinchen Shen, Shuyuan Wang, Baohui Han, Xueyan Zhang
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-29 - Crizotinib in Advanced Lung Adenocarcinoma Patients with ALK or ROS-1 Rearrangement: Is it the Same?
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Bo Zhang, Jianlin Xu, Yanwei Zhang, Xueyan Zhang, Tianqing Chu, Shuyuan Wang, Rong Qiao, Jie Qian, Jun Lu, Lele Zhang
- Abstract
Loading... -
+
P1.01-30 - Crizotinib in Advanced Non-Adenocarcinoma, NSCLC (NA-NSCLC) Patients with ALK Rearrangement: A Retrospective Study and Literature Review
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Bo Zhang, Yanwei Zhang, Jianlin Xu, Xueyan Zhang, Tianqing Chu, Shuyuan Wang, Jie Qian, Rong Qiao, Jun Lu, Lele Zhang
- Abstract
Loading...
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA15.07 - Different Responses to Osimertinib in Primary and Acquired EGFR T790M-Mutant NSCLC Patients
14:10 - 14:15 | Presenter: Shuyuan Wang | Author(s): Bo Zhang, Baohui Han
- Abstract
Loading...
-
+
P2.03 - Biology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.03-22 - OCT4&SOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC And Treating Drug-Resistant Lung Cancer Mice
16:45 - 18:00 | Presenter: Fang Hu | Author(s): Xueyan Zhang, Xiaoxuan Zheng, Bo Zhang, Huimin Wang, Guangyu Tao, Jianlin Xu, Yanwei Zhang, Baohui Han
- Abstract
Loading...
-
+
P2.11 - Screening and Early Detection (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.11-01 - Blood Transcriptomics Enables Detection of Pre-Invasive & Minimally-Invasive Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Fangfei Qian, Wenjia Yang, Xiang Zuo, Jie Qian, Bo Zhang, Shuyuan Wang, Lele Zhang
- Abstract
Loading...
-
+
P2.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.12-17 - Prophylactic Cranial Irradiation Can Not Provide Survival Benefits for Resected Small Cell Lung Cancer Without Lymph Node Involvement
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Jianlin Xu, Rong Qiao, Jiajun Teng, Bo Zhang, Shuyuan Wang, Jie Qian, Yuqing Lou, Yanwei Zhang, Xueyan Zhang, Xiaolong Fu, Tianqing Chu, Hua Zhong
- Abstract
Loading...
-
+
P3.13 - Targeted Therapy (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.13-09 - ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line
12:00 - 13:30 | Presenter: Baohui Han | Author(s): Jun Lu, Wei Zhang, Bo Yan, Lele Zhang, Jie Qian, Bo Zhang, Shuyuan Wang
- Abstract
Loading...